Genesis Capital is pleased to announce that Chroma Color Corporation (“Chroma”), a leading specialty color and additive concentrate supplier, has acquired Plastics Colors Corporation (“Plastics Color” or “PCC”). Chroma is a portfolio company of Arsenal Capital Partners (“Arsenal”).
Launched in 1964 under the name Kamco Plastics, Plastics Color originally focused on reprocessed color compounds. Its commitment to producing quality products led to rapid growth into dry color, white concentrate, color concentrate, and other additives. In 1989, Kamco Plastics officially changed its name to Plastics Color Corporation. With facilities in Illinois and North Carolina, Plastics Color became a well-known name in the plastics industry.
Tom Bolger, CEO of Chroma, noted, “PCC has had a strong base of customers and is known for solution-based products and strong service, both being pillars of Chroma’s offering. PCC’s presence in medical and pharmaceutical products, food packaging, CPG, and construction applications will bring more technologies and know-how to Chroma to allow us to better serve our customers and continue our growth.”
George Abd, an Operating Partner of Arsenal added, “This combination continues Chroma’s strategy of growth through both innovation and new product development as well as strategic business acquisitions. It was a pleasure working with the PCC and PMC Capital teams in completing this transaction.”
Stout Risius Ross Advisors, LLC acted as the investment banking advisor to Chroma, and Genesis Capital provided advisory services to Arsenal. The law firm of Benesch, Friedlander, Coplan & Aronoff LLP acted a legal counsel to Chroma.
About Chroma Color Corporation
Chroma Color Corporation is a leading specialty color and additive concentrate supplier serving the global plastics marketplace. Chroma’s extensive technical and manufacturing expertise coupled with its game-changing colorant technologies have enabled and delighted customers for over 50 years in diverse markets that include packaging, wire and cable, building & construction, consumer, medical, healthcare, lawn & garden, durables, sanitation, recreation and leisure, transportation and more.
About Arsenal Capital Partners
Arsenal is a leading private equity firm that specializes in investments in middle‐market specialty industrials and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of $5.3 billion, completed more than 45 platform investments and achieved more than 30 realizations. Arsenal invests in industry sectors in which the firm has significant prior knowledge and experience. The firm works with management teams to build strategically important companies with leading market positions, high growth, and high value-add.